financetom
Business
financetom
/
Business
/
Form 8.3 - Qualcomm Incorporated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3 - Qualcomm Incorporated
Sep 25, 2025 7:20 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Sand Grove Capital Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

Fund(s) for which Sand Grove Capital Management LLP serves as the Investment Manager or Discretionary Sub-Advisor

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Qualcomm Incorporated

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

24 September 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

Alphawave IP Group plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

 

USD 0.0001 common

 

 

 

Interests

 

Short positions

 

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

 

27,927

 

0.003%

(2) Cash-settled derivatives:

 

 

 

 

 

12,556

 

0.001%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

TOTAL:

 

 

 

 

 

40,483

 

0.004% 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

 

Purchase/sale

 

 

Number of securities

 

Price per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

USD 0.0001 common

 

CFD

 

Increasing a short position

 

900

 

172.135 USD

 

 

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Class of relevant security:

 

 

USD 0.0001 common

 

 

 

Interests

 

Short positions

 

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

 

27,927

 

0.003%

(2) Cash-settled derivatives:

 

 

 

 

 

12,556

 

0.001%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

TOTAL:

 

 

 

 

 

40,483

 

0.004% 

0

Class of relevant security:

 

 

USD 0.0001 common

 

 

 

Interests

 

Short positions

 

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

 

27,927

 

0.003%

(2) Cash-settled derivatives:

 

 

 

 

 

12,556

 

0.001%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

TOTAL:

 

 

 

 

 

40,483

 

0.004% 

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Source: Sand Grove Capital Management LLP

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Albemarle to Sell 51% of Ketjen to KPS, Exit Eurecat JV Stake for About $660 Million Cash
Albemarle to Sell 51% of Ketjen to KPS, Exit Eurecat JV Stake for About $660 Million Cash
Oct 27, 2025
08:17 AM EDT, 10/27/2025 (MT Newswires) -- Albemarle (ALB) said Monday it agreed to sell a 51% stake in Ketjen's refining catalyst business to KPS Capital Partners and its 50% interest in the Eurecat joint venture to Axens, expecting about $660 million in proceeds. On closing, KPS will own 51% and control Ketjen while Albemarle retains 49% and keeps the...
Nurix Therapeutics Closes $250 Million Underwritten Public Stock Offering
Nurix Therapeutics Closes $250 Million Underwritten Public Stock Offering
Oct 27, 2025
08:17 AM EDT, 10/27/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said Monday it has closed its underwritten offering of about 24.5 million shares priced at $10.21 per share and raising $250 million in gross proceeds. The clinical-stage biopharmaceutical firm said the offering included participation from new and existing investors, including General Atlantic, Redmile Group, Braidwell, Deep Track Capital...
Keurig Dr Pepper Signs $7 Billion Investment Agreements With Apollo, KKR Ahead of Planned Separation
Keurig Dr Pepper Signs $7 Billion Investment Agreements With Apollo, KKR Ahead of Planned Separation
Oct 27, 2025
08:17 AM EDT, 10/27/2025 (MT Newswires) -- Keurig Dr Pepper ( KDP ) said Monday it entered into two investment agreements totaling $7 billion, co-led by funds managed by Apollo (APO) and KKR (KKR), in connection with JDE Peet's acquisition and subsequent separation into two independent companies, Beverage Co. and Global Coffee Co. The first transaction involves a $4 billion...
Janus Henderson Group plc Confirms Acquisition Proposal from Trian and General Catalyst
Janus Henderson Group plc Confirms Acquisition Proposal from Trian and General Catalyst
Oct 27, 2025
LONDON--(BUSINESS WIRE)-- Janus Henderson Group plc ( JHG ) (“Janus Henderson” or the “Company”), announced that it has received a letter outlining a non-binding acquisition proposal (the “Proposal”) submitted jointly by Trian Fund Management, L.P. and its affiliated funds (“Trian”) and General Catalyst Group Management, LLC and its affiliated funds (“General Catalyst”). The Company’s board of directors intends to appoint...
Copyright 2023-2026 - www.financetom.com All Rights Reserved